Multibeam Maser Survey of methanol and excited OH in the Magellanic clouds: new detections and maser abundance estimates

‘The definitive version is available at www.blackwell-synergy.com.’ Copyright Blackwell Publishing DOI: 10.1111/j.1365-2966.2008.12888.xPeer reviewe

The Dark Matter halo of the Milky Way, AD 2013

We derive the mass model of the Milky Way (MW) using a cored dark matter (DM) halo profile and recent data. The method used consists in fitting a spherically symmetric model of the Galaxy with a Burkert DM halo profile to available data: MW terminal velocities in the region inside the solar circle, circular velocity as recently estimated from maser star forming regions at intermediate radii, and velocity dispersions of stellar halo tracers for the outermost Galactic region. The latter are reproduced by integrating the Jeans equation for every modeled mass distribution, and by allowing for different velocity anisotropies for different tracer populations. For comparison we also consider a Navarro-Frenk-White profile. We find that the cored profile is the preferred one, with a shallow central density of rho_H~4x10^7M_s/kpc^3 and a large core radius R_H~10 kpc, as observed in external spirals and in agreement with the mass model underlying the Universal Rotation Curve of spirals. We describe also the derived model uncertainties, which are crucially driven by the poorly constrained velocity dispersion anisotropies of halo tracers. The emerging cored DM distribution has implications for the DM annihilation angular profile, which is much less boosted in the Galactic center direction with respect to the case of the standard \Lambda CDM, NFW profile. Using the derived uncertainties we discuss finally the limitations and prospects to discriminate between cored and cusped DM profile with a possible observed diffuse DM annihilation signal. The present mass model aims to characterize the present-day description of the distribution of matter in our Galaxy, which is needed to frame current crucial issues of Cosmology, Astrophysics and Elementary Particles

Development of a heptaplex PCR assay for identification of Staphylococcus aureus and CoNS with simultaneous detection of virulence and antibiotic resistance genes

Background Staphylococcal toxicity and antibiotic resistance (STAAR) have been menacing public health. Although vancomycin-resistant Staphylococcus aureus (VRSA) is currently not as widespread as methicillin-resistant S. aureus (MRSA), genome evolution of MRSA into VRSA, including strains engineered within the same patient under anti-staphylococcal therapy, may build up to future public health concern. To further complicate diagnosis, infection control and anti-microbial chemotherapy, non-sterile sites such as the nares and the skin could contain both S. aureus and coagulase-negative staphylococci (CoNS), either of which could harbour mecA the gene driving staphylococcal methicillin-resistance and required for MRSA-VRSA evolution. Results A new heptaplex PCR assay has been developed which simultaneously detects seven markers for: i) eubacteria (16S rRNA), ii) Staphylococcus genus (tuf), iii) Staphylococcus aureus (spa), iv) CoNS (cns), v) Panton-Valentine leukocidin (pvl), vi) methicillin resistance (mecA), and vii) vancomycin resistance (vanA). Following successful validation using 255 reference bacterial strains, applicability to analyse clinical samples was evaluated by direct amplification in spiked blood cultures (n = 89) which returned 100 % specificity, negative and positive predictive values. The new assay has LoD of 1.0x103 CFU/mL for the 16S rRNA marker and 1.0x104 CFU/mL for six other markers and completes cycling in less than one hour. Conclusion The speed, sensitivity (100 %), NPV (100 %) and PPV (100 %) suggest the new heptaplex PCR assay could be easily integrated into a routine diagnostic microbiology workflow. Detection of the cns marker allows for unique identification of CoNS in mono-microbial and in poly-microbial samples containing mixtures of CoNS and S. aureus without recourse to the conventional elimination approach which is ambiguous. In addition to the SA-CoNS differential diagnostic essence of the new assay, inclusion of vanA primers will allow microbiology laboratories to stay ahead of the emerging MRSA-VRSA evolution. To the best of our knowledge, the new heptaplex PCR assay is the most multiplexed among similar PCR-based assays for simultaneous detection of STAAR

Aluminum oxide barrier coatings on polymer films for food packaging applications

In the field of packaging, barrier layers are functional films, which can be applied to polymeric substrates with the objective of enhancing their end-use properties. For food packaging applications, the packaging material is required to preserve packaged food stuffs and protect them from a variety of environmental influences, particularly moisture and oxygen ingress and UV radiation. Aluminum metallized films are widely used for this purpose. More recently, transparent barrier coatings based on aluminum oxide or silicon oxide have been introduced in order to fulfill requirements such as product visibility, microwaveability or retortability. With the demand for transparent barrier films for low-cost packaging applications growing, the use of high-speed vacuum deposition techniques, such as roll-to-roll metallizers, has become a favorable and powerful tool. In this study, aluminum oxide barrier coatings have been deposited onto biaxially oriented polypropylene and polyethylene terephthalate film substrates via reactive evaporation using an industrial 'boat-type' roll-to-roll metallizer. The coated films have been investigated and compared to uncoated films in terms of barrier properties, surface topography, roughness and surface energy using scanning electron microscopy, atomic force microscopy and contact angle measurement. Coating to substrate adhesion and coating thickness have been examined via peel tests and transmission electron microscopy, respectively. © 2013 Elsevier B.V

Nef Decreases HIV-1 Sensitivity to Neutralizing Antibodies that Target the Membrane-proximal External Region of TMgp41

Primate lentivirus nef is required for sustained virus replication in vivo and accelerated progression to AIDS. While exploring the mechanism by which Nef increases the infectivity of cell-free virions, we investigated a functional link between Nef and Env. Since we failed to detect an effect of Nef on the quantity of virion-associated Env, we searched for qualitative changes by examining whether Nef alters HIV-1 sensitivity to agents that target distinct features of Env. Nef conferred as much as 50-fold resistance to 2F5 and 4E10, two potent neutralizing monoclonal antibodies (nAbs) that target the membrane proximal external region (MPER) of TMgp41. In contrast, Nef had no effect on HIV-1 neutralization by MPER-specific nAb Z13e1, by the peptide inhibitor T20, nor by a panel of nAbs and other reagents targeting gp120. Resistance to neutralization by 2F5 and 4E10 was observed with Nef from a diverse range of HIV-1 and SIV isolates, as well as with HIV-1 virions bearing Env from CCR5- and CXCR4-tropic viruses, clade B and C viruses, or primary isolates. Functional analysis of a panel of Nef mutants revealed that this activity requires Nef myristoylation but that it is genetically separable from other Nef functions such as the ability to enhance virus infectivity and to downregulate CD4. Glycosylated-Gag from MoMLV substituted for Nef in conferring resistance to 2F5 and 4E10, indicating that this activity is conserved in a retrovirus that does not encode Nef. Given the reported membrane-dependence of MPER-recognition by 2F5 and 4E10, in contrast to the membrane-independence of Z13e1, the data here is consistent with a model in which Nef alters MPER recognition in the context of the virion membrane. Indeed, Nef and Glycosylated-Gag decreased the efficiency of virion capture by 2F5 and 4E10, but not by other nAbs. These studies demonstrate that Nef protects lentiviruses from one of the most broadly-acting classes of neutralizing antibodies. This newly discovered activity for Nef has important implications for anti-HIV-1 immunity and AIDS pathogenesis

Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020

We show the distribution of SARS-CoV-2 genetic clades over time and between countries and outline potential genomic surveillance objectives. We applied three available genomic nomenclature systems for SARS-CoV-2 to all sequence data from the WHO European Region available during the COVID-19 pandemic until 10 July 2020. We highlight the importance of real-time sequencing and data dissemination in a pandemic situation. We provide a comparison of the nomenclatures and lay a foundation for future European genomic surveillance of SARS-CoV-2.Peer reviewe